GRL-142
GRL-142 is a potent HIV-1 protease inhibitor capable of crossing the blood-brain barrier. GRL-142 exhibits extremely high inhibitory activity against both wild-type and multidrug-resistant strains (IC50=0.0094 nM). GRL-142 acts synergistically with the P2/P2' segments via a unique scaffold binding mechanism, utilizes fluorine-mediated stable interactions to maintain its bioactive conformation, adapts to p51 HIV-1 protease mutants, and maintains the flap-closed state by directly acting on the flap tip residues. GRL-142 disrupts the flap-water hydrogen bond network of wild-type protease, thereby effectively blocking viral replication. GRL-142 can be used to study HIV-1 infection and the associated neurocognitive disorder (HAND).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C34H40F2N4O7S2
- 分子量:718.83
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
HIV-1 |
GRL-142 exhibits ultra-potent inhibitory activity against wild-type HIV-1 (Ki=14 pM), and maintains high activity against most drug-resistant HIV-1 strains, but shows a significant reduction in activity against highly drug-resistant p51 strains (with a maximum reduction of 436-fold)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
分子量 718.83
-
分子式 C34H40F2N4O7S2
-
SMILES
[H][C@]1(C2CO[C@@]3(OCC4(C23)CC41)[H])OC(N[C@H]([C@@H](CN(S(=O)(C5=CC6=C(N=C(S6)NC7CC7)C=C5)=O)CC(C)C)O)CC8=CC(F)=CC(F)=C8)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- GRL-142
- GRL142
- GRL 142
- HIV
- HIV Protease
- flap-tip residue
- flap-water hydrogen bonding networks
- p51 HIV-1 protease variant
- drug-resistant HIV-1 strains
- blood-brain barrier
- HIV-associated neurocognitive disorders
- S2/S2' subsites
- multidrug-resistant HIV-1 protease
- HIV-1 infection
- wild-type HIV-1 protease
- Inhibitor
- inhibitor
- inhibit